PET/MRI accurately predicts risk of prostate cancer recurrence after prostatectomy


In men recently diagnosed with intermediate or high-grade prostate cancer, prostate specific membrane antigen (PSMA), PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy. Armed with this information, physicians can identify patients who could benefit from additional treatment and/or frequent surveillance. This research was published in the December issue of the Journal of Nuclear Medicine.

Vaccine and prior SARS-CoV-2 infection confer long-lasting protection against omicron BA.5

Previous article

Animals that carry seeds help regenerate forests

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations